Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Servo Controlled Oxygen Targeting (SCO2T): Servo Versus Servo

NCT04546568 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT04546568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Servo Controlled Oxygen Targeting (SCO2T): Servo Versus Servo
Lead sponsor
University of Edinburgh
Phase
Not applicable
Overall status
Terminated
Start date
August 10, 2020
Completion date
May 3, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperoxia, hypoxia, obstetric labor, premature, oxygen therapy, premature infant